liarozole has been researched along with Psoriasis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Decree, J; Degreef, H; Dockx, P | 1 |
Bergers, M; Boegheim, PJ; Den Bakker, JE; Kuijpers, AL; Schalkwijk, J; Siegenthaler, G; Van de Kerkhof, PC; Van Pelt, JP | 1 |
Berth-Jones, J; Hutchinson, PE; Thestrup-Pedersen, K; Todd, G; Vanhoutte, FP | 1 |
Bhushan, M; Burden, AD; Griffiths, CE; James, R; McElhone, K; Vanhoutte, FP | 1 |
4 trial(s) available for liarozole and Psoriasis
Article | Year |
---|---|
Inhibition of the metabolism of endogenous retinoic acid as treatment for severe psoriasis: an open study with oral liarozole.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites; Arthritis, Psoriatic; Female; Humans; Imidazoles; Male; Middle Aged; Psoriasis; Severity of Illness Index; Treatment Outcome; Tretinoin | 1995 |
The effects of oral liarozole on epidermal proliferation and differentiation in severe plaque psoriasis are comparable with those of acitretin.
Topics: Acitretin; Administration, Oral; Adult; Aged; Cell Differentiation; Cell Division; Double-Blind Method; Epidermis; Female; Humans; Imidazoles; Immunoenzyme Techniques; Keratolytic Agents; Leukocyte Count; Male; Middle Aged; Proteinase Inhibitory Proteins, Secretory; Proteins; Psoriasis; Serine Proteinase Inhibitors | 1998 |
Treatment of psoriasis with oral liarozole: a dose-ranging study.
Topics: Administration, Oral; Adolescent; Adult; Aged; Dermatologic Agents; Dose-Response Relationship, Drug; Female; Humans; Imidazoles; Male; Middle Aged; Psoriasis; Treatment Outcome | 2000 |
Oral liarozole in the treatment of palmoplantar pustular psoriasis: a randomized, double-blind, placebo-controlled study.
Topics: Administration, Oral; Adolescent; Adult; Aged; Dermatologic Agents; Double-Blind Method; Female; Follow-Up Studies; Humans; Imidazoles; Male; Middle Aged; Psoriasis; Severity of Illness Index; Treatment Outcome | 2001 |